“Nicotina doesn't protect against Coronavirus”, WHO against French study

Smoking damages lungs and other parts of your body and makes you more vulnerable to the Covid-19.” infection This is the message conveyed by the World Health Organization to put an end to any doubt after the French contravers study is published that nicotine can have a protective effect on the coronary.

The controversial French-hypothesis research on the effects “protectorial” of nicotine, which was published by the newspaper Le Monde, followed a study conducted by a team of experts from the Parisian La Pitié-Salpetrière hospital. According to preliminary data from research coming from clinical observation at the Parisian hospital, the rate of smoking among patients infected with Covid-19 by a sample of 350 patients with an average age of 65 would be very low, “roughly 5% of total. ”

Hypothesis-Professor Jean-Pierre Changeux, of the Pasteur Institute and College de France specified: “Hipotza is that nicotine, being fixed on the cell receptor used by the Coronavirus, prevents its penetrate into cells and spreading throughout the body. The sonic receptionist of acetilcolines” plays a major role in the spread of the coronary and is in the origin of the variety of symptoms of Covid-19, including loss of taste, smell, and other neurological disorders, until cases of sudden blocking of respiratory paths that could occur around the eighth day.

Epidemiologist: “Epidemiologist Florence Tuuch wanted to explain that based on these results, however powerful they are, we should not conclude that there is a protection effect of cigarette smoke, which contains many toxic agents.

“Only nicotine or nicotine receptor editors can have a protective effect, and these conditioned since we're still in the observation phase. ”

The French study followed that Chinese-To test the hypothesis, the Parisian hospital has launched an experiment based on nicotine's application with different doses and various prevention goals to see if it can help protect medical-health staff, as well as with the purpose of therapeutic for hospital patients, to see if, after nicotine application, there will be reduced symptoms or revivals.

By the end of March, a Chinese study published in the New England Journal of Medecine had highlighted the low percentage of smokers among the patients with Cove.

Anti-publishing French study responses, with an experiment launched in one of Paris' most important hospitals, sparked a quick response. “Do not go shopping nicotine,” said Health Minister Olivier Véran. The danger is to create false hopes among many smokers as well as create new cases with coronarys.

The general director of Health, Jerome Salmon, recalled that smoking causes 75,000 victims each year in France, and is a serious factor in cardiovascular, respiratory and cancer diseases.

The same caution has come from Italy.

“It is dangerous to praise a bad habit such as smoking and to think that it can help address what is now the epidemic emergency”, commented Giovanni Maga, director of the Medieval Institute of Genetics of the National Pavia Research Council.